Diseases
ISSN 2079-9721 · Multidisciplinary Digital Publishing Institute · Switzerland · active 1982–2026
Metrics
- Scimago quartile (2025)
- Q1
- Cites per paper (2y)
- 3.9
- SJR
- 0.919
- h-index
- 66
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.
Data as of 18 October 2026 (venue index build).
Scimago Journal Rank 2025
In the Scimago Journal Rank 2025 edition, Diseases is Q1 in Medicine (miscellaneous) (#600 of 2,517 journals).
| Subject category | Quartile | Rank in category |
|---|---|---|
| Medicine (miscellaneous) | Q1 | #600 of 2,517 |
- Cites per document (2 years, Scopus)
- 4.03
- Documents indexed in 2025 (Scopus)
- 405
The quartile is the one Scimago prints for each category. Rank is the journal's position by SJR among the journals Scimago lists in that category (#1 is the highest); “—” means we hold no rank consistent with that quartile. The document count is what Scopus indexed that year, which can be lower than a journal's full output. Source: SCImago Journal Rank 2025 edition, from Scopus data (scimagojr.com, CC BY-NC).
Diseases is Q1 in Medicine (miscellaneous) (2025 edition, #600 of 2,517 journals), with SJR 0.919 (Scimago) and an h-index of 66 (OpenAlex). Listed in DOAJ, Scopus, Web of Science, PubMed.
Is this the right journal for your paper?
The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.
Responding time
- Submission to first decision
- 22 days (median)Publisher-reported
- Submission to acceptance
- 42 days (median)Estimated from our library (436 papers)
- Acceptance to publication
- 3 days (median)Publisher-reported
- Submission to publication
- 45 days (median)Estimated from our library (436 papers)
Turnaround figures are indicative, not a guarantee: DOAJ values are self-reported by the journal (average weeks, submission to publication); library estimates are medians of the received/accepted dates printed in papers we hold. Editorial times vary by article type and season — confirm on the journal’s own site.
Indexing & access
- Indexed in
- DOAJScopusWeb of SciencePubMed
- Access status:
- gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
- Article processing charge
- Article processing charge (APC): 1,800 CHF per accepted article (DOAJ). Fee waivers are available.
Scope
Frequently asked
Is Diseases a predatory journal?
Our screening does not flag Diseases. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, Web of Science, PubMed, which is a positive signal.
Is Diseases indexed in Scopus or Web of Science?
Per our venue index, Diseases appears in: DOAJ, Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is the impact factor of Diseases?
Papers in Diseases are cited about 3.9 times each within two years of publication, and Scimago places it in Q1, with an h-index of 66. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.
What Scimago quartile is Diseases (Q1, Q2, Q3, or Q4)?
In the Scimago Journal Rank 2025 edition, Diseases is Q1 in Medicine (miscellaneous) (#600 of 2,517 journals). Quartiles split the journals in a subject category into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Diseases is cited about 3.9 times per paper over two years, with an h-index of 66.
What is the Web of Science (JCR) quartile of Diseases?
The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Diseases. The open equivalent is its Scimago quartile, Q1, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.
Is Diseases open access?
Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
What is the article processing charge (APC) to publish in Diseases?
Article processing charge (APC): 1,800 CHF per accepted article (DOAJ). Fee waivers are available. The exact charge can vary by article type and any fee waiver, so confirm the current amount on the journal's own site.
How long does Diseases take to publish a paper?
Submission to first decision for Diseases takes about 22 days (median) — Publisher-reported. Treat it as indicative rather than a guarantee: editorial times vary by article type, reviewer availability and season, and a self-reported figure is the journal's own. We do not hold a peer-review acceptance rate for Diseases.
Ready to submit? Tools for your next paper
Similar venues
- Expert Review of Anti-infective TherapyQ1 · Taylor & Francis
- Infection and ImmunityQ1 · American Society for Microbiology
- Microbial PathogenesisQ2 · Elsevier BV
- Microbiology SpectrumQ1 · American Society for Microbiology
- International Journal of Medical MicrobiologyQ1 · Elsevier BV
- Sexual HealthQ2 · CSIRO Publishing
Compare it with its peers: Ranked Infectious Diseases journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.